Funder JW, et al. (2016). The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 101(5), 1889-1916.
[2]
Stowasser M, et al. (2012). Familial Hyperaldosteronism. Hypertension, 59(5), 927-931.
[3]
Mulatero P, et al. (2013). Genetics of Primary Aldosteronism. Hypertension, 62(1), 27-32.
[4]
Vaidya A, et al. (2018). Primary Aldosteronism: State-of-the-Art Review. American Journal of Hypertension, 31(3), 267-274.
[5]
Wolley MJ, et al. (2016). Subtype Diagnosis of Primary Aldosteronism. Journal of Clinical Endocrinology & Metabolism, 101(4), 1376-1383.
[6]
Stowasser M. (2015). Primary Aldosteronism: Rare Cause or Common Condition? Endocrinology and Metabolism Clinics, 44(2), 199-216.
[7]
Milliez P, et al. (2005). Evidence for an Increased Rate of Cardiovascular Events in Patients with Primary Aldosteronism. Journal of the American College of Cardiology, 45(8), 1243-1248.
[8]
Hundemer GL, et al. (2018). Cardiometabolic Outcomes and Mortality in Medically Treated Primary Aldosteronism. The Lancet Diabetes & Endocrinology, 6(1), 51-59.
[9]
ICD-10-CM Diagnosis Code E26.8 - Other hyperaldosteronism. (n.d.). ICD-10Data.com.
[10]
Spät A, et al. (2017). Control of Aldosterone Secretion. Physiological Reviews, 84(2), 489-539.